Chemotherapy strategy for colorectal cancer under the outbreak of corona virus disease 2019
The outbreak of corona virus disease 2019 (COVID-19) makes the medical treatment of colorectal cancers difficult. Cancer patients are more susceptible to infection and tumor history is defined as an important factor of poor prognosis, which challenges both doctors and patients. For metastatic colorectal cancer (CRC) patients, maintenance therapy is the optimal choice. The patients with tumor progression or poor biological behavior should receive or continue combination chemotherapy. Adjuvant chemotherapy should reduce the intensity of treatment and shorten the therapy time. Fever patients during chemotherapy need to receive differential diagnosis and screening according to national standards. Patients with stable diseases and good general conditions may delay imaging examination. Clinicians should make individual clinical decisions based on the specifics of each patient during epidemic situation.
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2020 |
---|---|
Erschienen: |
2020 |
Enthalten in: |
Zur Gesamtaufnahme - volume:23 |
---|---|
Enthalten in: |
Zhonghua wei chang wai ke za zhi = Chinese journal of gastrointestinal surgery - 23(2020), 3 vom: 25. März, Seite 217-219 |
Sprache: |
Chinesisch |
---|
Beteiligte Personen: |
Li, Y H [VerfasserIn] |
---|
Links: |
---|
Themen: |
Chemotherapy |
---|
Anmerkungen: |
Date Completed 23.03.2020 Date Revised 18.12.2020 published: Print Citation Status MEDLINE |
---|
doi: |
10.3760/cma.j.cn.441530-20200225-00089 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM307787192 |
---|
LEADER | 01000naa a22002652 4500 | ||
---|---|---|---|
001 | NLM307787192 | ||
003 | DE-627 | ||
005 | 20231225130327.0 | ||
007 | cr uuu---uuuuu | ||
008 | 231225s2020 xx |||||o 00| ||chi c | ||
024 | 7 | |a 10.3760/cma.j.cn.441530-20200225-00089 |2 doi | |
028 | 5 | 2 | |a pubmed24n1025.xml |
035 | |a (DE-627)NLM307787192 | ||
035 | |a (NLM)32192297 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a chi | ||
100 | 1 | |a Li, Y H |e verfasserin |4 aut | |
245 | 1 | 0 | |a Chemotherapy strategy for colorectal cancer under the outbreak of corona virus disease 2019 |
264 | 1 | |c 2020 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Completed 23.03.2020 | ||
500 | |a Date Revised 18.12.2020 | ||
500 | |a published: Print | ||
500 | |a Citation Status MEDLINE | ||
520 | |a The outbreak of corona virus disease 2019 (COVID-19) makes the medical treatment of colorectal cancers difficult. Cancer patients are more susceptible to infection and tumor history is defined as an important factor of poor prognosis, which challenges both doctors and patients. For metastatic colorectal cancer (CRC) patients, maintenance therapy is the optimal choice. The patients with tumor progression or poor biological behavior should receive or continue combination chemotherapy. Adjuvant chemotherapy should reduce the intensity of treatment and shorten the therapy time. Fever patients during chemotherapy need to receive differential diagnosis and screening according to national standards. Patients with stable diseases and good general conditions may delay imaging examination. Clinicians should make individual clinical decisions based on the specifics of each patient during epidemic situation | ||
650 | 4 | |a Journal Article | |
650 | 4 | |a Chemotherapy | |
650 | 4 | |a Colorectal neoplasms | |
650 | 4 | |a Corona virus disease 2019 | |
700 | 1 | |a Shen, L |e verfasserin |4 aut | |
700 | 1 | |a Li, J |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Zhonghua wei chang wai ke za zhi = Chinese journal of gastrointestinal surgery |d 2005 |g 23(2020), 3 vom: 25. März, Seite 217-219 |w (DE-627)NLM157648419 |x 1671-0274 |7 nnns |
773 | 1 | 8 | |g volume:23 |g year:2020 |g number:3 |g day:25 |g month:03 |g pages:217-219 |
856 | 4 | 0 | |u http://dx.doi.org/10.3760/cma.j.cn.441530-20200225-00089 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 23 |j 2020 |e 3 |b 25 |c 03 |h 217-219 |